Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
1.
Nutr Diabetes ; 7(1): e241, 2017 01 16.
Artigo em Inglês | MEDLINE | ID: mdl-28092345

RESUMO

BACKGROUND: Acute ingestion of bitter melon (BM) has been shown to suppress the postprandial glycemic response in diabetics, but its impact on glucose regulation among individuals with impaired glucose tolerance is unclear. Moreover, one's glucose tolerance level may influence the effectiveness of BM. This study aimed to examine the acute effects of a beverage containing BM extract on blood glucose regulation during an oral glucose tolerance test (OGTT) among prediabetics. METHODS: Ten prediabetic adults completed two OGTTs-glucose only (D2) and glucose+BM (D3). Responders were identified as subjects whose area under the glucose curve (AUCglu) during D3 was lower than D2. To compare the acute effects of the beverage among individuals with varying glucose tolerance levels, subjects were grouped by their glucose response pattern-Fastpeak (peak glucose (Glupeak) at 30 min postglucose (30P)) and Slowpeak (Glupeak after 30P). RESULTS: During D3, responders (n=5) experienced a 13.2% reduction in AUCglu (95% confidence interval (CI): -18.1% to -8.3%), 12.2% reduction in mean glucose (95% CI: -17.3% to -7.0%) and 10.6% reduction in Glupeak (95% CI: -17.5% to -3.7%); plasma glucose was reduced by 9.1% at 30P (95% CI: -15.6% to -2.6%), -24.0% at 60P (95% CI: -36.8% to -11.2%) and -20.0% at 90P (95% CI: -35.8% to -4.2%) during D3. No between-trial differences were noted for Fastpeak or Slowpeak. CONCLUSIONS: Acute ingestion of BM prior to the second OGTT (D3) led to a reduced postprandial glucose response in 50% of the subjects but did not affect the insulin response. Furthermore, the effectiveness of the beverage was seemingly uninfluenced by the subjects' glucose tolerance level. Although BM has shown to aid blood glucose management in diabetics, it remains uncertain why only a portion of subjects responded positively to the BM extract in the current study.


Assuntos
Glicemia/análise , Momordica charantia , Extratos Vegetais/administração & dosagem , Período Pós-Prandial/efeitos dos fármacos , Estado Pré-Diabético/sangue , Idoso , Bebidas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Período Pós-Prandial/fisiologia , Resultado do Tratamento
2.
Physiol Meas ; 35(1): 31-43, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24345800

RESUMO

The purpose of this study was to examine the validity and reliability of estimated parameters of the work-time relationship during cross-country ski ergometry using the traditional multi-trial critical power (CP) test and a 3 min 'all-out' test (3MT). Fourteen recreationally active male participants (mean ± SD; age: 22.14 ± 2.85 yrs; height: 177.09 ± 6.57 cm; weight: 85.68 ± 13.56 kg) completed three testing visits. All testing was conducted using an upper-body ergometer (SkiErg, Concept2, Inc., Morrisville, VT). A graded exercise test was used to determined maximal oxygen uptake (VO2peak). Two separate 3MT sessions were used to determine oxygen uptake (VO23MT), end-test power (EP), work above end-test power (WEP) and end stroke rate (ESR). Additionally, three time trials completed in a single day at simulated distances of 300 m, 650 m and 1000 m were used to estimate CP, W' and critical stroke rate (CSR). VO2peak (3.65 ± 0.50 l · min(-1)) and VO23MT (3.59 ± 0.4 l · min(-1)) were not significantly different (p = 0.162). Intraclass correlation coefficients for EP, WEP and ESR were 0.809, 0.611 and 0.783, respectively. EP (148 ± 33 W) and CP (157 ± 49 W), were not significantly different between the testing methodologies (p = 0.290) and were highly correlated (r = 0.780). WEP (8.4 ± 3.0 kJ) and W' (8.3 ± 3.0 kJ) were similar (p = 0.947) but not related (r = 0.119), while ESR (45 ± 7 spm) and CSR (47 ± 7 spm) values were not significantly different (p = 0.238) and moderately correlated (r = 0.498). The 3MT using ski ergometry was shown to produce concurrently valid results with the traditional multi-trial CP test for CP and CSR, but not W', and elicited similar maximal oxygen uptake values when compared to a graded exercise test.


Assuntos
Ergometria/métodos , Esqui/fisiologia , Adulto , Teste de Esforço , Humanos , Masculino , Oxigênio/metabolismo , Fatores de Tempo , Adulto Jovem
3.
Eur J Clin Nutr ; 67 Suppl 1: S40-6, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23299870

RESUMO

BACKGROUND/OBJECTIVES: To compare single estimations of fat-free mass (FFM) and to track FFM using single-frequency bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA) compared with a four-compartment (4C) model in healthy elderly Americans. SUBJECTS/METHODS: Thirty-four men and thirty-eight women (Caucasian, ≥ 65 years) were included in the study. Subjects participated in either the control group or the exercise group. All testing and training took place during the 21-week investigation. Body composition assessments using nine BIA equations, DXA and a 4C model were performed during weeks 1, 12 and 24 of the study. RESULTS: Single estimations for DXA and BIA produced high r values (0.79-0.95) and low standard error of estimate values (1.62-3.3 kg), producing subjective ratings of 'ideal' for men and 'excellent' for women. Both DXA and two BIA equations revealed the same significance when comparing groups and times with the 4C model. Individual accuracy for tracking changes was similar among BIA equations and DXA compared with the 4C model, with a total agreement of 25% for BIA and 27% for DXA compared with the 4C model. CONCLUSIONS: The current data in combination with the reliability errors for both BIA and DXA FFM estimations suggest that individual results should be interpreted with caution if FFM changes are <5 kg. However, DXA and BIA are both valid methods that can be used interchangeably to estimate FFM at a single time point or for tracking changes in FFM in small groups (15-22) of healthy American older adults.


Assuntos
Absorciometria de Fóton/métodos , Antropometria/métodos , Composição Corporal , Compartimentos de Líquidos Corporais , Impedância Elétrica , Idoso , Exercício Físico , Feminino , Humanos , Masculino , Conceitos Matemáticos , Modelos Biológicos , Valores de Referência , Reprodutibilidade dos Testes , Fatores Sexuais , Estados Unidos , População Branca
4.
Amino Acids ; 43(1): 77-90, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22102056

RESUMO

The purpose of this study was to evaluate the effects of ß-alanine supplementation on markers of oxidative stress. Twenty-four women (age: 21.7±2.1 years; VO2max: 2.6±0.3 l min(-1)) were randomly assigned, in a double-blind fashion, to a ß-alanine (BA, 2×800 mg tablets, 3× daily; CarnoSyn®; n=13) or placebo (PL, 2×800 mg maltodextrin tablets, 3× daily; n=11) group. A graded oxygen consumption test (VO2max) was performed to evaluate VO2max, time to exhaustion, ventilatory threshold and establish peak velocity (PV). A 40-min treadmill run was used to induce oxidative stress. Total antioxidant capacity, superoxide dismutase, 8-isoprostane (8ISO) and reduced glutathione were measured. Heart rate and ratings of perceived exertion were recorded during the 40 min run. Separate three- [4×2×2; acute (base vs. IP vs. 2 vs. 4 h)×chronic (pre- vs. post-)×treatment (BA vs. PL)] and two- [2×2; time (pre-supplement vs. post-supplement)×treatment (BA vs. PL)] way ANOVAs were used for analyses. There was a significant increase in VO2max (p=0.009), independent of treatment, with no significant changes in TTE (p=0.074) or VT (p=0.344). Ratings of perceived exertion values were significantly improved from pre- to post-supplementation for the BA group only at 40 min (p=0.02). The ANOVA model demonstrated no significant treatment effects on oxidative stress. The chronic effects of BA supplementation demonstrated little antioxidant potential, in women, and little influence on aerobic performance assessments.


Assuntos
Estresse Oxidativo/efeitos dos fármacos , Consumo de Oxigênio/efeitos dos fármacos , Resistência Física/efeitos dos fármacos , Corrida/fisiologia , beta-Alanina/farmacologia , Carnosina/metabolismo , Suplementos Nutricionais , Dinoprosta/análogos & derivados , Dinoprosta/sangue , Método Duplo-Cego , Teste de Esforço/efeitos dos fármacos , Feminino , Glutationa/sangue , Frequência Cardíaca/efeitos dos fármacos , Humanos , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/sangue , Adulto Jovem , beta-Alanina/administração & dosagem
5.
Int J Sports Med ; 32(12): 975-81, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22131203

RESUMO

This study evaluated the effects of creatine (Cr) loading and sex differences on aerobic running performance. 27 men (mean±SD; age: 22.2±3.1 years, ht: 179.5±8.7 cm, wt: 78.0±9.8 kg) and 28 women (age: 21.2±2.1 years, ht: 166.0±5.8 cm, wt: 63.4±8.9 kg) were randomly assigned to either creatine (Cr, di-creatine citrate; n=27) or a placebo (PL; n=28) group, ingesting 1 packet 4 times daily (total of 20 g/day) for 5 days. Aerobic power (maximal oxygen consumption: VO2max) was assessed before and after supplementation using open circuit spirometry (Parvo-Medics) during graded exercise tests on a treadmill. 4 high-speed runs to exhaustion were conducted at 110, 105, 100, and 90% of peak velocity to determine critical velocity (CV). Distances achieved were plotted over times-to-exhaustion and linear regression was used to determine the slopes (critical velocity, CV) assessing aerobic performance. The results indicated that Cr loading did not positively or negatively influence VO2max, CV, time to exhaustion or body mass (p>0.05). These results suggest Cr supplementation may be used in aerobic running activities without detriments to performance.


Assuntos
Creatina/farmacologia , Suplementos Nutricionais , Exercício Físico/fisiologia , Contração Isométrica/fisiologia , Força Muscular/fisiologia , Análise de Variância , Composição Corporal , Índice de Massa Corporal , Peso Corporal , Método Duplo-Cego , Teste de Esforço , Feminino , Humanos , Masculino , Consumo de Oxigênio/fisiologia , Fatores Sexuais , Adulto Jovem
7.
Appl Opt ; 46(5): 643-7, 2007 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-17279148

RESUMO

We describe the results of a comparison of reference standards between three National Metrology Institutes: the National Institute of Standards and Technology (NIST, USA), the National Metrology Institute of Japan/National Institute of Advanced Industrial Science and Technology (NMIJ/AIST, Japan), and the Federal Office of Metrology (METAS, Switzerland). Open-beam- (free field) and optical-fiber-based measurements at wavelengths of 1302 and 1546 nm are reported. Three laboratories' reference standards are compared by means of two temperature-controlled, optical trap detectors. Measurement results show the largest differences of less than 4.2 parts in 10(3), which is within the expanded (k=2) uncertainty for the laboratories' reference standards.

8.
Heart ; 92(6): 759-62, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16216858

RESUMO

OBJECTIVES: To investigate the relation between aortic stiffness and coronary flow reserve (CFR) in patients with coronary artery disease (CAD). DESIGN: Observational study. SETTING: Coronary care unit of a primary care hospital. PATIENTS: 192 consecutive patients who underwent coronary angiography. MAIN OUTCOME MEASURE: Brachial-ankle pulse wave velocity (ba-PWV), CFR, and severity of CAD. RESULTS: According to the angiographic findings, patients were divided into four subgroups: patients without significant stenosis (normal coronary artery (NCA) group, n = 28) and those with one vessel disease (1VD group, n = 92), two vessel disease (2VD group, n = 50), or three vessel disease (3VD group, n = 22). ba-PWV increased with the number of diseased vessels and was significantly correlated with the number of diseased vessels (NCA group v 1VD group v 2VD group v 3VD group: 1481 (252) v 1505 (278) v 1577 (266) v 1727 (347) cm/s, p < 0.001). CFR had a significant negative correlation with ba-PWV (r = -0.45, p < 0.0001). The diastolic to systolic velocity ratio obtained in 45 patients also was significantly correlated with ba-PWV (r = -0.35, p < 0.05). Multiple regression analysis showed that ba-PWV was an independent determinant of CFR (p < 0.01). CONCLUSIONS: Coronary flow is altered with aortic stiffening in patients with CAD. These results suggest one possible mechanism for recent reports that aortic stiffness is a key cardiovascular risk factor.


Assuntos
Doenças da Aorta/fisiopatologia , Doença da Artéria Coronariana/fisiopatologia , Tornozelo/irrigação sanguínea , Aorta/fisiopatologia , Doenças da Aorta/diagnóstico por imagem , Velocidade do Fluxo Sanguíneo/fisiologia , Artéria Braquial/fisiologia , Angiografia Coronária , Doença da Artéria Coronariana/diagnóstico por imagem , Circulação Coronária/fisiologia , Estenose Coronária/fisiopatologia , Elasticidade , Feminino , Humanos , Masculino , Microcirculação , Pessoa de Meia-Idade , Fluxo Pulsátil/fisiologia , Resistência Vascular/fisiologia
9.
Heart ; 90(5): 528-33, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15084551

RESUMO

OBJECTIVE: To investigate whether concentrations of plasma adiponectin constitute a significant coronary risk factor, with particular focus on the relation between plasma concentrations of adiponectin and the development of acute coronary syndrome (ACS). SUBJECTS AND METHODS: Plasma concentrations of adiponectin were measured in 123 patients with coronary artery disease (CAD) and in 17 control participants. Patients were divided into three groups according to condition type: acute myocardial infarction (AMI) group (n = 59), unstable angina pectoris (UAP) group (n = 28), and stable angina pectoris (SAP) group (n = 36). RESULTS: Plasma concentrations of adiponectin correlated negatively with body mass index (r = -0.18, p < 0.05), serum triglyceride (r = -0.25, p < 0.01), and fasting glucose concentrations (r = -0.21, p < 0.05), but correlated positively with age (r = 0.26, p < 0.01), high density lipoprotein cholesterol concentrations (r = 0.35, p < 0.01), and low density lipoprotein particle size (r = 0.37, p < 0.01). Plasma concentrations of adiponectin in patients with ACS, in both the AMI and UAP groups, were significantly lower than those in patients with SAP and in the control group (ACS, 6.5 (3.0) microg/ml; SAP, 11.3 (5.9) micro g/ml; control 12.8 (4.3) microg/ml; p < 0.01). Additionally, plasma concentrations of adiponectin in patients with CAD (7.9 (4.6) microg/ml, p < 0.01) were significantly lower than in the control group. There were, however, no significant differences between patients with SAP and the control group (p = 0.36). Multiple logistic regression analysis showed that smoking, fasting glucose concentration, and low log adiponectin concentration correlated independently with the development of an ACS. CONCLUSIONS: The findings suggest that measurement of plasma concentrations of adiponectin may be of use for assessing the risk of CAD and may be related to the development of ACS.


Assuntos
Doença da Artéria Coronariana/sangue , Peptídeos e Proteínas de Sinalização Intercelular , Proteínas/análise , Adiponectina , Adulto , Idoso , Idoso de 80 Anos ou mais , Angina Pectoris/sangue , Índice de Massa Corporal , LDL-Colesterol/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/sangue , Fatores de Risco , Triglicerídeos/sangue
10.
Heart ; 89(1): 71-6, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12482796

RESUMO

OBJECTIVES: To investigate the relation between coronary flow reserve (CFR), coronary zero flow pressure (Pzf), and residual myocardial viability in patients with acute myocardial infarction. DESIGNS: Prospective study. SETTING: Primary care hospital. PATIENTS: 27 consecutive patients with acute anterior myocardial infarction. MAIN OUTCOME MEASURES: F-fluorodeoxyglucose (FDG) positron emission tomography (PET) was used in 27 patients who underwent successful intervention within 12 hours of onset of a first acute anterior myocardial infarction. Within three days before discharge they had < 25% stenosis in the culprit lesion as determined by angiography 24 (3) days after acute myocardial infarction. Pzf and the slope index of the flow-pressure relation (SIFP) were calculated from the simultaneously recorded aortic pressure and coronary flow velocity signals at peak hyperaemia.%FDG was quantified by comparing FDG uptake in the infarct myocardium with FDG uptake in the normal myocardium. RESULTS: There was a correlation between %FDG and CFR, where y = -1.477x + 62.517, r = -0.072 (NS). There was also a correlation between %FDG and SIFP, where y = -0.975x + 60.542, r = -0.045 (NS), and a significant correlation between %FDG and Pzf, where y = -0.98x + 85.108, r = -0.696 (p < 0.001). CONCLUSIONS: CFR does not correlate with FDG-PET at the time of postreperfusion evaluation of residual myocardial viability. The parameter that correlates best with residual myocardial viability is Pzf and this may be a useful index for predicting patient prognosis.


Assuntos
Circulação Coronária/fisiologia , Infarto do Miocárdio/fisiopatologia , Miocárdio , Sobrevivência de Tecidos , Idoso , Angioplastia com Balão/métodos , Velocidade do Fluxo Sanguíneo/fisiologia , Angiografia Coronária/métodos , Estenose Coronária/complicações , Estenose Coronária/terapia , Ecocardiografia/métodos , Feminino , Fluordesoxiglucose F18 , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/etiologia , Infarto do Miocárdio/terapia , Reperfusão Miocárdica/métodos , Estudos Prospectivos , Compostos Radiofarmacêuticos , Terapia Trombolítica/métodos , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Vasodilatadores/uso terapêutico , Disfunção Ventricular Esquerda/fisiopatologia
11.
J Assoc Nurses AIDS Care ; 12(4): 77-88, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11486723

RESUMO

This study measured quantitatively and explored qualitatively silencing behaviors and affectivity (mood) in women living with HIV/AIDS and confirmed the validity of the Silencing the Self Scale and the Positive and Negative Affect Scale. Silencing behaviors are interpersonal communication styles that suppress personal needs and feelings to preserve relationships with others. Silencing behaviors serve as protective strategies that allow one to divorce oneself from an overbearing culture. Affectivity is a way of measuring one's personal mood state by a positive to negative continuum. The results indicate that the women silenced themselves profoundly, especially when it came to putting the needs of their children or dependents before their own. The women also had high levels of negative affectivity. The research findings from this study extend nursing knowledge by addressing the unique social processes of women living with HIV/AIDS within health care service structures and significant social groups. Further exploration of "silencing" as a phenomenon of this group through measurement and experience will help define specific interventions that are meaningful to and for women living with HIV/AIDS.


Assuntos
Afeto , Ego , Infecções por HIV/psicologia , Testes Psicológicos , Comportamento Social , Adulto , Altruísmo , Boston , Estudos Transversais , Feminino , Infecções por HIV/enfermagem , Humanos , Relações Interpessoais , Projetos Piloto , Reprodutibilidade dos Testes
12.
Heart ; 85(4): 402-6, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11250964

RESUMO

OBJECTIVE: To use intravascular ultrasound (IVUS) to compare plaque morphology in acute myocardial infarction and stable angina pectoris. DESIGN: Retrospective study. SETTING: Primary care hospital. PATIENTS: 59 consecutive cases of acute myocardial infarction and 50 consecutive cases of stable angina pectoris. METHODS: IVUS was used before coronary intervention. MAIN OUTCOME MEASURES: Plaque morphology (incidence of eccentric plaque, subtle dissections, low echoic thrombus, calcification, echolucent areas, and bright speckled echo material), assessed visually using IVUS. RESULTS: There were no significant differences in plaque eccentricity or calcification between the two groups, but low echoic thrombus (acute myocardial infarction 15% v stable angina pectoris 0%), subtle dissections (37% v 4%), echolucent areas (31% v 0%), and bright speckled echo material (90% v 0%) were more common in the infarction group than in the stable angina group (p < 0.001 for all). There was a longer time between the onset of symptoms and the IVUS examination in patients with low echoic thrombus than in those without (p < 0.03). CONCLUSIONS: Low echoic thrombus, subtle dissections, echolucent areas, and bright speckled echo material are morphological characteristics associated with plaque at the time of acute myocardial infarction. These findings correspond pathologically to ruptured plaque.


Assuntos
Infarto do Miocárdio/diagnóstico por imagem , Ultrassonografia de Intervenção , Angina Pectoris/diagnóstico por imagem , Angina Pectoris/patologia , Angiografia Coronária , Doença das Coronárias/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/patologia , Estudos Retrospectivos
14.
Biochem Pharmacol ; 42(10): 2019-26, 1991 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-1683772

RESUMO

A semi-naphthoquinone natural product, A80915A, produced by Streptomyces aculeolatus was found to be a potent inhibitor of gastric (H(+)-K+)-ATPase, the enzyme responsible for acid secretion in the stomach. Enzyme activity was measured by potassium-stimulated hydrolysis of ATP or p-nitrophenolphosphate with enzyme prepared from the stomach fundic mucosa of pigs. Concentration-dependent inhibition was observed with an IC50 of about 2-3 microM for both ATPase and p-nitrophenylphosphatase. A Hill plot indicated that the enzyme has two binding sites for A80915A. Inhibition was not affected by the presence of the reducing agent dithiothreitol, indicating a lack of involvement of enzyme sulfhydryl groups. A 30-min incubation of enzyme with increasing drug concentrations followed by a 10-fold dilution did not alter the IC50, indicating that A80915A does not covalently modify the enzyme. Coincubation of enzyme with 3.8 microM A80915A resulted in time-dependent inhibition. The rate of inhibition was slowed significantly by the presence of 20 mM potassium, rubidium and ammonium but not by 20 mM sodium, lithium and choline, or by 40 mM sucrose. The level of inhibition was influenced by the order of addition of potassium and drug to the enzyme. Taken together, these studies indicate that inhibition by A80915A is dependent on the conformation of gastric (H(+)-K+)-ATPase and that potassium slows the rate of inhibition by converting the enzyme to a conformation where the drug binding site is not as accessible. The mode of action of A80915A is distinct from that of two well characterized proton pump inhibitors, omeprazole and SCH 28080.


Assuntos
Adenosina Trifosfatases/antagonistas & inibidores , Antibacterianos/farmacologia , Mucosa Gástrica/efeitos dos fármacos , Fosfatase Alcalina/metabolismo , Animais , Ditiotreitol/farmacologia , Relação Dose-Resposta a Droga , Mucosa Gástrica/enzimologia , ATPase Trocadora de Hidrogênio-Potássio , Imidazóis/farmacologia , Cinética , Naftoquinonas/farmacologia , Omeprazol/farmacologia , Potássio/farmacologia , Conformação Proteica , Suínos , Fatores de Tempo , gama-Glutamiltransferase/metabolismo
15.
J Antibiot (Tokyo) ; 43(6): 587-93, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2380106

RESUMO

A54145 is a complex of new lipopeptide antibiotics that inhibits Gram-positive bacteria and acts as a growth promotant for broiler chicks. Eight factors; A, B, C, D, E, F, A1 and B1; have been isolated and characterized. They contain four similar peptide nuclei, each of which is acylated with either an 2-decanoyl, n-decanoyl, or undecanoyl side chain. Taxonomic studies ascertained that the producing microorganism was a strain of Streptomyces fradiae. Fermentation studies determined that superior antibiotic yields were obtained in stirred bioreactors in a soybean flour-molasses medium employing a continuous glucose feed. These findings, interwoven with the selection of hyper-productive mutants, increased fermentation yields from less than 50 micrograms/ml to more than 1 mg/ml. An analytical HPLC system was developed for the identification and subsequent quantitation of each factor of the A54145 complex.


Assuntos
Antibacterianos/biossíntese , Microbiologia do Solo , Streptomyces/metabolismo , Sequência de Aminoácidos , Animais , Antibacterianos/análise , Cromatografia Líquida de Alta Pressão , Fermentação , Lipoproteínas/análise , Lipoproteínas/biossíntese , Dados de Sequência Molecular , Streptomyces/classificação
16.
J Antibiot (Tokyo) ; 43(6): 594-600, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2380107

RESUMO

A54145 is a complex of acidic lipopeptide antibiotics which are produced by Streptomyces fradiae and are active against Gram-positive bacteria. The A54145 complex was isolated by adsorption on Diaion HP-20 nonfunctionalized macroreticular resin and/or ion exchange on Amberlite IRA-68 anion exchange resin. Antibacterial factors A, A1, B, B1, C, D, E, and F were obtained in purified form by repeated preparative reverse phase HPLC on C8 and/or C18 bonded-phase supports. The molecular formulae of the factors are C72H109N17O27 (factors A and A1), C73H111N17O27 (factors B, B1, C, and D), C74H113N17O27 (factor E), and C71H107N17O27 (factor F). The identities of the acyl side chains were established as 8-methylnonanoyl (factors F, A, and B1), n-decanoyl (factors A1 and B), and 8-methyldecanoyl (factors C, D, and E).


Assuntos
Antibacterianos/isolamento & purificação , Adsorção , Sequência de Aminoácidos , Aminoácidos/análise , Antibacterianos/análise , Cromatografia Líquida de Alta Pressão , Cromatografia por Troca Iônica , Lipoproteínas/análise , Lipoproteínas/isolamento & purificação , Dados de Sequência Molecular , Solubilidade , Espectrofotometria Ultravioleta , Streptomyces/metabolismo
17.
J Antibiot (Tokyo) ; 43(6): 601-6, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2380108

RESUMO

A54145 is a complex of acidic lipopeptide antibiotics produced by Streptomyces fradiae NRRL 18158, NRRL 18159, and NRRL 18160. Each antibiotic factor consists of a peptide core bearing an N-terminal acyl substituent. N-Lys-tert-BOC-protected A54145 complex was deacylated by Actinoplanes utahensis; three protected core peptides were isolated. A54145 antibiotic analogs were synthesized by acylation of the tryptophan N-terminus with 2,4,5-trichlorophenyl active esters, followed by deblocking with trifluoroacetic acid.


Assuntos
Antibacterianos/metabolismo , Actinomycetales/metabolismo , Acilação , Sequência de Aminoácidos , Lipoproteínas/metabolismo , Dados de Sequência Molecular
18.
J Antibiot (Tokyo) ; 43(6): 616-22, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2380110

RESUMO

A54145 complex is made up of eight factors; A, A1, B, B1, C, D, E, and F which were active in vitro (MIC 0.25 approximately greater than 32 micrograms/ml) against Gram-positive aerobic organisms. The complex, factor B and B1 were found to be active against two strains of Clostridium perfringens. A calcium dependence study on some of the factors showed that their in vitro antibacterial activity was greatly enhanced by the presence of calcium (50 mg/liter) in the media. Resistance build-up was seen when Staphylococcus sp. and Streptococcus sp. were passed seven times in the presence of sublethal concentrations of A54145 antibiotics. This resistance disappeared immediately when the resistant organisms were passed in the absence of the antibiotics. Factor A was very effective against Staphylococcus aureus and Streptococcus pyogenes infections in mice (sc ED50s of 3.3 approximately 2.4 mg/kg x 2, respectively). Factor B was more active against S. pyogenes in vivo (sc ED50, 0.9 mg/kg x 2). Acute mouse toxicities were determined with these antibiotics. Semisynthetic derivatives were evaluated.


Assuntos
Antibacterianos/farmacologia , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus/efeitos dos fármacos , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Antibacterianos/uso terapêutico , Antibacterianos/toxicidade , Cálcio/metabolismo , Clostridium perfringens/efeitos dos fármacos , Meios de Cultura , Resistência Microbiana a Medicamentos , Lipoproteínas/farmacologia , Lipoproteínas/uso terapêutico , Lipoproteínas/toxicidade , Camundongos , Camundongos Endogâmicos ICR , Dados de Sequência Molecular , Estrutura Molecular
19.
J Antibiot (Tokyo) ; 43(6): 623-33, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1696251

RESUMO

New semi-naphthaquinone antibiotics A80915A, B, C, and D were isolated from the fermented broth of Streptomyces aculeolatus A80915 (NRRL 18422). Factors A and C, present in both the broth filtrate and mycelial methanol extract, and factors B and D, found predominantly in the broth filtrate, were recovered by extraction with ethyl acetate. Purification of the individual factors was accomplished by preparative reverse phase high performance liquid chromatograph on C18 bonded silica supports. Factors A through D show antimicrobial activity against Gram-positive aerobic and anaerobic organisms in vitro. Mechanism of action studies demonstrated nearly complete inhibition of macromolecular biosynthesis (protein, RNA, DNA, and cell wall) by A80915 factors A through D. A less highly cyclized semi-naphthaquinone, A80915 factor G, was isolated from the broth of the strain fermented in an alternate medium.


Assuntos
Antibacterianos/biossíntese , Bactérias/efeitos dos fármacos , Microbiologia do Solo , Streptomyces/metabolismo , Animais , Antibacterianos/análise , Antibacterianos/isolamento & purificação , Antibacterianos/farmacologia , Bactérias/genética , Bactérias/metabolismo , Proteínas de Bactérias/biossíntese , Proteínas de Bactérias/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , DNA Bacteriano/biossíntese , DNA Bacteriano/efeitos dos fármacos , Fermentação , Camundongos , Microscopia Eletrônica de Varredura , Estrutura Molecular , Naftoquinonas/análise , Naftoquinonas/isolamento & purificação , Naftoquinonas/metabolismo , Naftoquinonas/farmacologia , RNA Bacteriano/biossíntese , RNA Bacteriano/efeitos dos fármacos , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estreptocócicas/tratamento farmacológico , Streptomyces/classificação , Streptomyces/ultraestrutura
20.
Gan No Rinsho ; 35(9): 1087-92, 1989 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-2671432

RESUMO

A retroperitoneal leiomyosarcoma in a 50-year-old man is reported. A laparotomy was performed on Dec. 17, 1987 and the tumor, weighing 120 g, was completely excised. The patient was followed up and has stayed healthy (1 year after operation). Although CT ultrasonography and arteriography are helpful in the diagnosis of retroperitoneal tumors, it is felt that a histological examination is indispensable for a qualitative assessment of the lesion. Surgical excision constitutes the fundamental treatment for a retroperitoneal leiomyosarcoma. However, the prognosis is usually poor and depends on successful radical surgery. This case involved non-concurrent double cancers with a retroperitoneal leiomyosarcoma and a kidney cancer.


Assuntos
Neoplasias Renais/patologia , Leiomiossarcoma/patologia , Neoplasias Primárias Múltiplas , Neoplasias Retroperitoneais/patologia , Humanos , Leiomiossarcoma/diagnóstico , Leiomiossarcoma/cirurgia , Masculino , Pessoa de Meia-Idade , Neoplasias Retroperitoneais/diagnóstico , Neoplasias Retroperitoneais/cirurgia , Tomografia Computadorizada por Raios X , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...